Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03873415 · ClinicalTrials.gov registry record · Phase 1
Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy Males
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT03873415 is a Phase 1 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 9 participants.
The verdict
NCT03873415, a Phase 1 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate sites of gut absorption of BMS-986165 in males
Interventions
- DRUG BMS-986165
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-01-25 |
| Est. Completion | 2019-05-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03873415
The ClinicalTrials.gov registry entry for NCT03873415 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BMS-986165 is the first listed.
NCT03873415 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03873415 about?
NCT03873415 is a clinical study titled "Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy Males". The purpose of this study is to evaluate sites of gut absorption of BMS-986165 in males
What is the current status of trial NCT03873415?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2019-01-25. Estimated completion is 2019-05-01.
What interventions are being tested in trial NCT03873415?
The interventions under investigation include: BMS-986165 (DRUG).
Who is sponsoring clinical trial NCT03873415?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.